Christophe Ramière1,2,3, Caroline Charre1,3,4, Patrick Miailhes5, François Bailly6, Sylvie Radenne6, Anne-Claire Uhres7, Corinne Brochier8, Matthieu Godinot5, Pierre Chiarello5, Pierre Pradat8, Laurent Cotte5,4. 1. Virology Laboratory, Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Lyon, France. 2. Centre International de Recherche en Infectiologie, INSERM, CNRS UMR, Lyon, France. 3. University of Lyon, Université Claude Bernard Lyon, Villeurbanne, France. 4. INSERM U1052, Lyon, France. 5. Infectious Diseases Department, Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Lyon, France. 6. Hepatology Department, Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Lyon, France. 7. Pharmacy, Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Lyon, France. 8. Clinical Research Centre, Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Lyon, France.
Abstract
BACKGROUND: Sexually transmitted acute hepatitis C virus (HCV) infections (AHIs) have been mainly described in human immunodeficiency virus (HIV)-infected men who have sex with men (MSM). Cases in HIV-negative MSM are scarce. We describe the epidemic of AHI in HIV-infected and HIV-negative MSM in Lyon, France. METHODS: All cases of AHI diagnosed in MSM in Lyon University Hospital from 2014 to 2017 were included. AHI incidence was determined in HIV-infected and in preexposure prophylaxis (PrEP)-using MSM. Transmission clusters were identified by construction of phylogenetic trees based on HCV NS5B (genotype 1a/4d) or NS5A (genotype 3a) Sanger sequencing. RESULTS: From 2014 to 2017, 108 AHIs (80 first infections, 28 reinfections) were reported in 96 MSM (HIV-infected, 72; HIV-negative, 24). AHI incidence rose from 1.1/100 person-years (95 confidence interval [CI], 0.7-1.7) in 2014 to 2.4/100 person-years (95 CI, 1.1-2.6) in 2017 in HIV-infected MSM (P = .05) and from 0.3/100 person-years (95 CI, 0.06-1.0) in 2016 to 3.4/100 person-years (95 CI, 2.0-5.5) in 2017 in PrEP users (P < .001). Eleven clusters were identified. All clusters included HIV-infected MSM; 6 also included HIV-negative MSM. All clusters started with ≥1 HIV-infected MSM. Risk factor distribution varied among clusters. CONCLUSIONS: AHI incidence increased in both HIV-infected and HIV-negative MSM. Cluster analysis suggests initial transmission from HIV-infected to HIV-negative MSM through chemsex and traumatic sexual practices, leading to mixed patterns of transmission regardless of HIV status and no overlap with the general population.
BACKGROUND: Sexually transmitted acute hepatitis C virus (HCV) infections (AHIs) have been mainly described in human immunodeficiency virus (HIV)-infectedmen who have sex with men (MSM). Cases in HIV-negative MSM are scarce. We describe the epidemic of AHI in HIV-infected and HIV-negative MSM in Lyon, France. METHODS: All cases of AHI diagnosed in MSM in Lyon University Hospital from 2014 to 2017 were included. AHI incidence was determined in HIV-infected and in preexposure prophylaxis (PrEP)-using MSM. Transmission clusters were identified by construction of phylogenetic trees based on HCV NS5B (genotype 1a/4d) or NS5A (genotype 3a) Sanger sequencing. RESULTS: From 2014 to 2017, 108 AHIs (80 first infections, 28 reinfections) were reported in 96 MSM (HIV-infected, 72; HIV-negative, 24). AHI incidence rose from 1.1/100 person-years (95 confidence interval [CI], 0.7-1.7) in 2014 to 2.4/100 person-years (95 CI, 1.1-2.6) in 2017 in HIV-infected MSM (P = .05) and from 0.3/100 person-years (95 CI, 0.06-1.0) in 2016 to 3.4/100 person-years (95 CI, 2.0-5.5) in 2017 in PrEP users (P < .001). Eleven clusters were identified. All clusters included HIV-infected MSM; 6 also included HIV-negative MSM. All clusters started with ≥1 HIV-infected MSM. Risk factor distribution varied among clusters. CONCLUSIONS: AHI incidence increased in both HIV-infected and HIV-negative MSM. Cluster analysis suggests initial transmission from HIV-infected to HIV-negative MSM through chemsex and traumatic sexual practices, leading to mixed patterns of transmission regardless of HIV status and no overlap with the general population.
Authors: Steven J Clipman; Priya Duggal; Aylur K Srikrishnan; Shanmugam Saravanan; Pachamuthu Balakrishnan; Canjeevaran K Vasudevan; David D Celentano; David L Thomas; Shruti H Mehta; Sunil S Solomon Journal: J Infect Dis Date: 2020-05-11 Impact factor: 5.226
Authors: Carmen Hidalgo-Tenorio; Concepción Gil-Anguita; Miguel Angel López Ruz; Mohamed Omar; Javier López-Hidalgo; Juan Pasquau Journal: PLoS One Date: 2019-10-24 Impact factor: 3.240
Authors: Kaitlin M McGrew; Hélène Carabin; Tabitha Garwe; S Reza Jafarzadeh; Mary B Williams; Yan Daniel Zhao; Douglas A Drevets Journal: Drug Alcohol Depend Date: 2020-03-04 Impact factor: 4.852
Authors: T Sonia Boender; Eline Op de Coul; Joop Arends; Maria Prins; Marc van der Valk; Jan T M van der Meer; Birgit van Benthem; Peter Reiss; Colette Smit Journal: Euro Surveill Date: 2020-02
Authors: Stephanie Popping; Brooke Nichols; Bart Rijnders; Jeroen van Kampen; Annelies Verbon; Charles Boucher; David van de Vijver Journal: J Virus Erad Date: 2019-11-04
Authors: Tamara Prinsenberg; Sjoerd Rebers; Anders Boyd; Freke Zuure; Maria Prins; Marc van der Valk; Janke Schinkel Journal: PLoS One Date: 2020-04-14 Impact factor: 3.240